Nkarta Announces November & December 2020 Investor Conference Schedule

SOUTH SAN FRANCISCO, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced its participation at these upcoming investor conferences:

Cowen 2020 IO Next SummitDate: Friday, November 13, 2020Fireside chat presentation: 11:45 a.m. ET

Stifel 2020 Virtual Healthcare ConferenceDate: Tuesday, November 17, 2020Fireside chat presentation: 2:00 p.m. ET

Evercore ISI 3rd Annual HealthCONx ConferenceDate: Tuesday, December 1, 2020Fireside chat presentation: 9:40 a.m. ET

A live audio webcast of the event will be available on the Investors section of Nkarta’s website, www.nkartatx.com. A replay of the webcast will be archived on the website for approximately four weeks.

About NkartaNkarta is a clinical-stage biotechnology company advancing the development of allogeneic natural killer (NK) cell therapies for cancer. By combining its cell expansion and cryopreservation platform with proprietary cell engineering technologies, Nkarta is building a pipeline of cell therapy candidates generated by efficient manufacturing processes, and engineered to enhance tumor targeting and improve persistence for sustained activity in the body. For more information, please visit the company’s website at www.nkartatx.com.

Nkarta Media/Investor Contact:Greg MannNkarta, Inc.[email protected]

You May Also Be Interested In

• New High-Grade Domain Discovered at Cuffley
• Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
• Solana Unchained Emerges as a Closely Watched Solana Presale Following Product Ecosystem Reveal